J P Morgan Chase & Co Analysts Give Fresenius Medical Care AG & Co. (Pref) (FME) a €95.10 Price Target

Fresenius Medical Care AG & Co. (Pref) (ETR:FME) has been assigned a €95.10 ($111.88) price target by stock analysts at J P Morgan Chase & Co in a report issued on Wednesday. The brokerage currently has a “buy” rating on the stock.

Several other analysts have also issued reports on the company. Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Friday, September 29th. Berenberg Bank set a €95.60 ($112.47) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Tuesday, September 19th. Morgan Stanley set a €90.00 ($105.88) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Friday, September 15th. Citigroup Inc. set a €92.00 ($108.24) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Tuesday, August 8th. Finally, Deutsche Bank AG set a €84.00 ($98.82) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “neutral” rating in a report on Tuesday, August 8th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of €88.39 ($103.98).

Fresenius Medical Care AG & Co. (ETR:FME) opened at 81.202 on Wednesday. Fresenius Medical Care AG & Co. has a 1-year low of €70.82 and a 1-year high of €89.07. The firm has a market capitalization of €24.92 billion and a price-to-earnings ratio of 20.939. The company has a 50-day moving average price of €80.87 and a 200 day moving average price of €82.07.

WARNING: This news story was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/10/11/j-p-morgan-chase-95-10-price-target.html.

About Fresenius Medical Care AG & Co. (Pref)

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply